Sunday, March 31, 2019

UPDATED: Amarin takes application to expand Vascepa label to the FDA as M&A chatter heats up - Endpoints News

  1. UPDATED: Amarin takes application to expand Vascepa label to the FDA as M&A chatter heats up  Endpoints News
  2. Vascepa sNDA Seeking Expanded Indication to Reduce Major CV Events  Monthly Prescribing Reference
  3. View full coverage on Google News
(CLICK HERE TO READ AND SEE MORE

0 comments:

Post a Comment